Investigating Argonaute phosphorylation and miR-134 as novel therapeutic targets for Alzheimer's disease
Investigating Argonaute phosphorylation and miR-134 as novel therapeutic targets for Alzheimer's disease
批准号:
2131974
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2018
资助国家:
英国
项目状态:
已结题
起止时间:
2018 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
During the pre-clinical period of Alzheimer's Disease (AD) significant deficits in synaptic transmission and dendritic spine loss develop. This process underpins the circuit dysfunction and cognitive decline seen in later stages of the disease. MicroRNAs (miRNAs) are small non-coding RNAs involved in RNA-mediated silencing of synaptic proteins via Argonaute (Ago) as part of the RNA-induced Silencing Complex (RISC). miRNAs are known to be involved in regulation of synapses and dendrite morphology and specific miRNAs have been implicated in the pathogenesis of AD. However, how RISC protein machinery is affected by AD pathology is less well understood. Preliminary data from this lab suggests that phosphorylation of Ago at S387 and binding of Ago to RISC scaffold protein GW182 is increased in the hAPP-J20 mouse model of AD. This suggests that miRNA activity may be dysregulated as a consquence of AD-related pathology and contributing to spine loss and synaptic dysfunction. Hypothesis: Blocking Ago phosphorylation at S387 in models of amyloidopathy will reduce synaptic deficits and spine shrinkage observed in these models via resetting of miRNA activity.Methods: Endogenous Argonaute will be replaced with phospho-null mutant in primary neuronal cultures overexpressing APP and miRNA activity will be quantified using dual luciferase assays using luciferase reporter constructs carrying the 3'UTR seed sequence of key synaptic proteins. In a mouse model of amyloidopathy the following three rescue strategies will be utilised by use of stereotactic injection into the CA1 region of the hippocampus: a) lentiviral replacement of endogenous Argonaute with a phospho-null mutant, b) lentiviral overexpression of key synaptic protein 3) Antagomirs to bind and repress activity of key synaptic miRNAs.Slices will be prepared from these mice for electrophysiological recording and spine analysis by confocal microscopy to assess synaptic function and dendrite morphology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
Argonaute纳米通道传感平台的构建及其在中药材真菌毒素多重检测中的应用
-
批准号:JCZRLH202600719
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
高活性Argonaute核酸酶创制及新型编辑系统开发
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
无催化活性的原核Argonaute的guide核酸产生和识别机制
-
批准号:JCZRQN202500359
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
基于“双钥匙-锁”识别策略的结直肠癌外泌体Argonaute2-microRNA原位检测方法研究
-
批准号:MS25B050018
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:王丹阳
-
依托单位:
基于Argonaute可编程核酸酶的高灵敏动物疫病检测技术研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
可编程核酸酶Argonaute的催化机制及
其驱动的DNA大片段合成组装技术研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
基于光响应的可再生二维 DNA 阵列的构建及
其在胃癌外泌体内 Argonaute 2-microRNA 复
合物检测中的研究
-
批准号:TGC24B050011
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:夏垚坤
-
依托单位:
基于原核Argonaute蛋白质的新型RNA靶向敲低技术
-
批准号:32300517
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:刘洋
-
依托单位:
基于可编程核酸酶Argonaute的DNA高效合成及组装技术研究
-
批准号:32301221
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:陈晚苹
-
依托单位:
新型Argonaute‒Csm6‒DNAzyme生物传感机制用于食源性致病菌超灵敏与现场化检测的研究
-
批准号:32372415
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:马龙
-
依托单位: